Laura I. Bushnell net worth and biography

Laura Bushnell Biography and Net Worth

Director of Vincerx Pharma
Laura Bushnell, JD is a member of Vincerx’s board of directors. Ms Bushnell has served as a partner of King & Spalding LLP, a global corporate law firm, since September 2009. Ms Bushnell has served as a member of the board of trustees of the University of California, Santa Cruz, Foundation since February 2015, and as chair of the Dean’s Council of the Baskin School of Engineering at the University of California, Santa Cruz, since July 2019. Since September 2010, Ms Bushnell has served as a member of the board of directors of the Legal Aid Society of San Mateo County. Ms Bushnell received an AB in psychology from Stanford University and a JD from the Georgetown University Law Center.

What is Laura I. Bushnell's net worth?

The estimated net worth of Laura I. Bushnell is at least $13,441.40 as of June 9th, 2022. Ms. Bushnell owns 19,202 shares of Vincerx Pharma stock worth more than $13,441 as of December 1st. This net worth evaluation does not reflect any other investments that Ms. Bushnell may own. Learn More about Laura I. Bushnell's net worth.

How do I contact Laura I. Bushnell?

The corporate mailing address for Ms. Bushnell and other Vincerx Pharma executives is 260 SHERIDAN AVENUE SUITE 400, PALO ALTO CA, 94306. Vincerx Pharma can also be reached via phone at 650-800-6676. Learn More on Laura I. Bushnell's contact information.

Has Laura I. Bushnell been buying or selling shares of Vincerx Pharma?

Laura I. Bushnell has not been actively trading shares of Vincerx Pharma during the last ninety days. Most recently, on Thursday, June 9th, Laura I. Bushnell bought 15,000 shares of Vincerx Pharma stock. The stock was acquired at an average cost of $1.91 per share, with a total value of $28,650.00. Following the completion of the transaction, the director now directly owns 19,202 shares of the company's stock, valued at $36,675.82. Learn More on Laura I. Bushnell's trading history.

Who are Vincerx Pharma's active insiders?

Vincerx Pharma's insider roster includes Laura Bushnell (Director), Ahmed Hamdy (CEO), Raquel Izumi (Insider), Andrew McDonald (Director), Alexander Seelenberger (CFO), and Tom Thomas (Insider). Learn More on Vincerx Pharma's active insiders.

Are insiders buying or selling shares of Vincerx Pharma?

During the last year, Vincerx Pharma insiders bought shares 8 times. They purchased a total of 109,869 shares worth more than $274,555.74. The most recent insider tranaction occured on August, 24th when Director Christopher P Lowe bought 18,400 shares worth more than $30,360.00. Insiders at Vincerx Pharma own 23.6 % of the company. Learn More about insider trades at Vincerx Pharma.

Information on this page was last updated on 8/24/2022.

Laura I. Bushnell Insider Trading History at Vincerx Pharma

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/9/2022Buy15,000$1.91$28,650.0019,202View SEC Filing Icon  
12/22/2021Buy2,402$10.48$25,172.96View SEC Filing Icon  
See Full Table

Laura I. Bushnell Buying and Selling Activity at Vincerx Pharma

This chart shows Laura I Bushnell's buying and selling at Vincerx Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Vincerx Pharma Company Overview

Vincerx Pharma logo
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candidates include VIP217, an oral PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate to treat solid tumors; and VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is headquartered in Palo Alto, California.
Read More

Today's Range

Now: $0.70
Low: $0.66
High: $0.71

50 Day Range

MA: $1.00
Low: $0.67
High: $1.38

2 Week Range

Now: $0.70
Low: $0.65
High: $11.42


81,995 shs

Average Volume

175,528 shs

Market Capitalization

$14.83 million

P/E Ratio


Dividend Yield